BNTX

BioNTech SE (BNTX)

Last Price$122.90.6%
Market Cap$29.5B
LTM Net Debt to Free Cash Flow
(16.7x)
5Y avg
(0.9x)
Biotechnology industry median
0.9x
Stock quality & Intrinsic value
6/10
0.3% undervalued

BioNTech SE Net Debt to Free Cash Flow

Annual
Quarterly
LTM
Industry median
Company stand-alone
BNTX
Healthcare
Crunching data... Almost there!
Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Net Debt to Free Cash Flow
0.0x
1.6x
3.3x
1.9x
10.3x
(2.2x)
(1.1x)
(3.5x)
BNTX
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for BNTX and see if it's the right time to invest.
Dive in

BioNTech SE (BNTX) Net Debt to Free Cash Flow comparison analysis

Crunching data... Almost there!

BNTX key stats

USD
EUR
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is BioNTech SE's Net Debt to Free Cash Flow?

As of today, Microsoft Corp's last 12-month Net Debt to Free Cash Flow is (16.7x), based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Net Debt to Free Cash Flow for BioNTech SE have been (2.8x) over the past three years, and (0.9x) over the past five years.

2) Is BioNTech SE's Net Debt to Free Cash Flow Good?

As of today, BioNTech SE's Net Debt to Free Cash Flow is (16.7x), which is lower than industry median of 0.9x. It indicates that BioNTech SE's Net Debt to Free Cash Flow is Good.

3) How does BioNTech SE's Net Debt to Free Cash Flow compare to its peers?

As of today, BioNTech SE's Net Debt to Free Cash Flow is (16.7x), which is lower than peer median of (1.2x). The list of peers includes VRTX, BGNE, MRNA, NVO, REGN, GMAB, UTHR, ALNY, INCY, ARGX.